24 April 2017 - Deborah Wilkes
Archived
The pharmaceutical industry is calling for a swift decision on the new location of the European Medicines Agency (EMA), following the UK's decision to leave the European Union. The new location must have "world class connectivity", says the industry, which also stresses the importance of retaining "highly competent staff".
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.